Surgery therapy for polypoidal choroidal vasculopathy / 中华实验眼科杂志
Chinese Journal of Experimental Ophthalmology
; (12): 629-632, 2020.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-865325
Biblioteca responsável:
WPRO
ABSTRACT
With the development of intraocular injection of anti-vascular endothelial growth factor (VEGF) drugs, early treatment of polypoidal choroidal vasculopathy (PCV) has more understanding and development.Once PCV combined with vitreous hemorrhage, treatment becomes much more difficult.The causes of vitreous hemorrhage in PCV, treatment of PCV with vitreous hemorrhage by different surgical methods, including simple vitrectomy, vitreous gas injection, intraoperative combined with vitrectomy and PDT, vitrectomy combined with CF 6, retinal pigment epithelium transplantation and other vitrectomy, as well as common operation complications, postoperative recurrence and prognosis are summarized in this article.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Tipo de estudo:
Estudo prognóstico
Idioma:
Chinês
Revista:
Chinese Journal of Experimental Ophthalmology
Ano de publicação:
2020
Tipo de documento:
Artigo